Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Artur, Belov"'
Autor:
Behzad Naderalvojoud, Nilpa D. Shah, Jane N. Mutanga, Artur Belov, Rebecca Staiger, Jonathan H. Chen, Barbee Whitaker, Tina Hernandez-Boussard
Publikováno v:
Vaccines, Vol 11, Iss 11, p 1712 (2023)
Seasonal influenza is a leading cause of death in the U.S., causing significant morbidity, mortality, and economic burden. Despite the proven efficacy of vaccinations, rates remain notably low, especially among Medicaid enrollees. Leveraging Medicaid
Externí odkaz:
https://doaj.org/article/f3fd681c0a7b47099a3af985271685c7
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology, Vol 10, Iss 4, Pp 286-290 (2021)
Abstract As part of the US Food and Drug Administration (FDA)’s Prescription Drug User Fee Act (PDUFA) VI commitments, the Center for Biologics Evaluation and Research (CBER) and Center for Drug Evaluation and Research (CDER) are conducting a model
Externí odkaz:
https://doaj.org/article/5f1a7d7dc0cd4e0ca2b90c5d2f271522
Autor:
Matthew Deady, Hussein Ezzeldin, Kerry Cook, Douglas Billings, Jeno Pizarro, Amalia A. Plotogea, Patrick Saunders-Hastings, Artur Belov, Barbee I. Whitaker, Steven A. Anderson
Publikováno v:
Frontiers in Digital Health, Vol 3 (2021)
Introduction: The Food and Drug Administration Center for Biologics Evaluation and Research conducts post-market surveillance of biologic products to ensure their safety and effectiveness. Studies have found that common vaccine exposures may be missi
Externí odkaz:
https://doaj.org/article/7978c182c73f4c5ebd545a9020addb41
Autor:
Artur, Belov, Hong, Yang, Richard A, Forshee, Barbee I, Whitaker, Anne F, Eder, Caren, Chancey, Steven A, Anderson
Publikováno v:
JAIDS Journal of Acquired Immune Deficiency Syndromes. 92:173-179
Blood donations are routinely screened for human immunodeficiency virus (HIV) to prevent an infectious unit from being released to the blood supply. Despite improvements to blood screening assays, donations from infected donors remain undetectable du
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bbe690cbbbecbb76c29f1b271ce783b
https://doi.org/10.1097/qai.0000000000003115
https://doi.org/10.1097/qai.0000000000003115
Autor:
Barbee Whitaker, Jeno Pizarro, Matthew Deady, Alan Williams, Hussein Ezzeldin, Artur Belov, Sami Kanderian, Douglas Billings, Kerry Cook, Aaron Z. Hettinger, Steven Anderson
Publikováno v:
Transfusion. 62:2029-2038
Transfusion-related adverse events can be unrecognized and unreported. As part of the US Food and Drug Administration's Center for Biologics Evaluation and Research Biologics Effectiveness and Safety initiative, we explored whether machine learning m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5337a09264c24c5c0b32e74c03b3adce
https://doi.org/10.1111/trf.17069
https://doi.org/10.1111/trf.17069
Autor:
Michelle Wang, Gregory M. Goldgof, Ayan Patel, Barbee Whitaker, Artur Belov, Brian Chan, Evan Phelps, Benjamin Rubin, Steven Anderson, Atul J. Butte
Publikováno v:
Transfusion.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7c2a4e414520c3add2533c31626437d0
https://doi.org/10.1111/trf.17447
https://doi.org/10.1111/trf.17447
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology, Vol 10, Iss 4, Pp 286-290 (2021)
CPT: Pharmacometrics & Systems Pharmacology
CPT: Pharmacometrics & Systems Pharmacology
As part of the US Food and Drug Administration (FDA)’s Prescription Drug User Fee Act (PDUFA) VI commitments, the Center for Biologics Evaluation and Research (CBER) and Center for Drug Evaluation and Research (CDER) are conducting a model‐inform
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6089ac5d2b2898a50e00736bb1ae35b5
https://doi.org/10.1002/psp4.12597
https://doi.org/10.1002/psp4.12597
Autor:
Perrin Jhaveri, Selen Bozkurt, Axel Moyal, Artur Belov, Steven Anderson, Hua Shan, Barbee Whitaker, Tina Hernandez‐Boussard
Publikováno v:
Transfusion
Blood transfusions are a vital component of modern healthcare, yet adverse reactions to blood product transfusions can cause morbidity, and rarely result in mortality. Therefore, accurate reporting of transfusion related adverse events (TRAEs) is par
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e46e6d387a1fb81499fa899ce28766f2
https://europepmc.org/articles/PMC9450944/
https://europepmc.org/articles/PMC9450944/
Autor:
Artur, Belov, Yin, Huang, Carlos H, Villa, Barbee I, Whitaker, Richard, Forshee, Steven A, Anderson, Anne, Eder, Nicole, Verdun, Michael J, Joyner, Scott R, Wright, Rickey E, Carter, Deborah T, Hung, Mary, Homer, Corey, Hoffman, Michael, Lauer, Peter, Marks
Publikováno v:
American journal of hematology. 97(6)
The efficacy of COVID-19 convalescent plasma (CCP) as a treatment for hospitalized patients with COVID-19 remains somewhat controversial; however, many studies have not evaluated CCP documented to have high neutralizing antibody titer by a highly acc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2da571f44811ea1f0e9112ee77ac50e
https://pubmed.ncbi.nlm.nih.gov/35303377
https://pubmed.ncbi.nlm.nih.gov/35303377
Publikováno v:
Haemophilia. 26:817-825
INTRODUCTION Emerging, systematic approaches for capturing patient input, such as preference elicitation, can provide valuable information for the benefit-risk assessment of medical products for treating bleeding disorders, such as haemophilia. AIM T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd92cb44980cc03ae1534c4b81c73842
https://doi.org/10.1111/hae.14119
https://doi.org/10.1111/hae.14119